The following is an excerpt from a S-1 SEC Filing, filed by TARGANTA THERAPEUTICS CORP. on 5/11/2007.
-- Use Sections To Navigate Through The Document --
FORM S-1
CALCULATION OF REGISTRATION FEE
SUBJECT TO COMPLETION, DATED MAY 11, 2007
TABLE OF CONTENTS
PROSPECTUS SUMMARY
THE OFFERING
SUMMARY CONSOLIDATED FINANCIAL INFORMATION
RISK FACTORS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND ...
USE OF PROCEEDS
DIVIDEND POLICY
CAPITALIZATION
DILUTION
BENEFICIAL OWNERS
SELECTED CONSOLIDATED FINANCIAL DATA
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ...
Liquidity and Capital Resources
OPTIONS
BUSINESS
Competition
Legal Proceedings
Employees
MANAGEMENT
NAME AND TITLE
NAME AND TITLE
Executive Compensation
COMPENSATION TABLE
Director Compensation
2005 Stock Option Plan
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Indemnification
Review and Approval of Related Party Transactions
PRINCIPAL STOCKHOLDERS
BENEFICIAL OWNERS
DESCRIPTION OF CAPITAL STOCK
Transfer Agent and Registrar
SHARES ELIGIBLE FOR FUTURE SALE
UNDERWRITING
LEGAL MATTERS
EXPERTS
WHERE YOU CAN FIND MORE INFORMATION
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
BALANCE SHEET
INCOME STATEMENT
STOCKHOLDERS EQUITY
STOCKHOLDERS EQUITY
STOCKHOLDERS EQUITY
CASH FLOW
Notes to Consolidated Financial Statements
PART II
Item 13. Other Expenses of Issuance and Distribution.
Item 14. Indemnification of Directors and Officers.
Item 15. Recent Sales of Unregistered Securities
Item 16. Exhibits.
Item 17. Undertakings.
SIGNATURES
SIGNATURES AND POWER OF ATTORNEY
EXHIBIT INDEX
EXHIBIT 3.1
CERTIFICATE OF INCORPORATION
EXHIBIT 4.2
EXHIBIT 10.1
EXHIBIT 10.1.1
EXHIBIT 10.1.2
EXHIBIT 10.1.3
EXHIBIT 10.1.4
EXHIBIT 10.3
EXHIBIT 10.4
EXHIBIT 10.7
EXHIBIT 10.7.1
EXHIBIT 10.12
EXHIBIT 10.13
EXHIBIT 10.14
EXHIBIT 10.15
EXHIBIT 10.17
EXHIBIT 10.18
EXHIBIT 10.19
EXHIBIT 10.20
EXHIBIT 21.1
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
TARGANTA THERAPEUTICS CORP. - S-1 - 20070511 - NAME_AND_TITLE
Other Management Members
The following table sets
forth certain information about other members of our management team, including their ages and positions as of April 13, 2007:
Name
Age
Position(s)
Christian Bélisle
48
Vice President, Finance & Administration and Secretary
Gayle C. Fischer
56
Vice President, Marketing
Paul D. Gesellchen, Ph.D.
58
Vice President, Regulatory Affairs
Stanley W. Merrill
48
Vice President, Human Resources
Roger Miller
57
Vice President, Operations and Manufacturing
Margaret Wasilewski, M.D.
49
Vice President, Clinical Development and Medical Science Team Leader
Next Section
Previous Section